{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:37Z","timestamp":1777936177004,"version":"3.51.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.5857-25","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:07:58Z","timestamp":1759961278000},"page":"1227-1232","source":"Crossref","is-referenced-by-count":0,"title":["&lt;sup&gt;123&lt;\/sup&gt;I-MIBG Scintigraphy-negative Pheochromocytoma without Hypertension Found During Follow-up for Non-functioning Adrenal Incidentaloma"],"prefix":"10.2169","volume":"65","author":[{"given":"Tomohiko","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoatsu","family":"Mune","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Abe I, Islam F, Lam AK. Glucose intolerance on phaeochromocytoma and paraganglioma - the current understanding and clinical perspectives. Front Endocrinol (Lausanne) 11: 593780, 2020.","DOI":"10.3389\/fendo.2020.593780"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamazaki Y, Gao X, Pecori A, et al. Recent advances in histopathological and molecular diagnosis in pheochromocytoma and paraganglioma: challenges for predicting metastasis in individual patients. Front Endocrinol (Lausanne) 11: 587769, 2020.","DOI":"10.3389\/fendo.2020.587769"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fang F, Ding L, He Q, Liu M. Preoperative management of pheochromocytoma and paraganglioma. Front Endocrinol (Lausanne) 11: 586795, 2020.","DOI":"10.3389\/fendo.2020.586795"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xing J, Cheng Y, Ying H, Guan M, Jia N, Bai C. Systemic treatment of a metastatic carotid body tumor: a case report and literature review. Medicine (Baltimore) 99: e22811, 2020.","DOI":"10.1097\/MD.0000000000022811"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tanabe A, Naruse M. Recent advances in the management of pheochromocytoma and paraganglioma. Hypertens Res 43: 1141-1151, 2020.","DOI":"10.1038\/s41440-020-0531-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sbardella E, Grossman AB. Pheochromocytoma: an approach to diagnosis. Best Pract Res Clin Endocrinol Metab 34: 101346, 2020.","DOI":"10.1016\/j.beem.2019.101346"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366: 665-675, 2005.","DOI":"10.1016\/S0140-6736(05)67139-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bernardi S, Calabr\u00f2 V, Cavallaro M, et al. Is the adrenal incidentaloma functionally active? An approach-to-the-patient-based review. J Clin Med 11: 4064, 2022.","DOI":"10.3390\/jcm11144064"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Plouin PF, Amar L, Dekkers OM, et al.; Guideline Working Group. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174: G1-G10, 2016.","DOI":"10.1530\/EJE-16-0033"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mori H, Wakabayashi H, Saito S, et al. Evaluating the diagnostic efficacy of whole-body MRI versus <sup>123<\/sup>I-MIBG\/<sup>131<\/sup>I-MIBG imaging in metastatic pheochromocytoma and paraganglioma. Sci Rep 14: 13828, 2024.","DOI":"10.1038\/s41598-024-64607-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wachtel H, Hutchens T, Baraban E, et al. Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems. J Clin Endocrinol Metab 105: e4661-e4670, 2020.","DOI":"10.1210\/clinem\/dgaa608"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Timmers HJ, Kozupa A, Chen CC, et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25: 2262-2269, 2007.","DOI":"10.1200\/JCO.2006.09.6297"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Timmers HJ, Chen CC, Carrasquillo JA, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by <sup>18<\/sup>F-fluorodeoxyglucose (<sup>18<\/sup>F-FDG) positron emission tomography. J Natl Cancer Inst 104: 700-708, 2012.","DOI":"10.1093\/jnci\/djs188"},{"key":"14","unstructured":"14. Van Der Horst-Schrivers AN, Jager PL, Boezen HM, Schouten JP, Kema IP, Links TP. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas - experience and meta-analysis. Anticancer Res 26 (2B): 1599-1604, 2006."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology 212: 35-41, 1999.","DOI":"10.1148\/radiology.212.1.r99jl3035"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hoegerle S, Nitzsche E, Altehoefer C, et al. Pheochromocytomas: detection with <sup>18<\/sup>F DOPA whole-body PET - initial results. Radiology 222: 507-512, 2002.","DOI":"10.1148\/radiol.2222010622"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol 33: 90-114, 2022.","DOI":"10.1007\/s12022-022-09704-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Taubman I, Pearson OH, Anton AH. An asymptomatic catecholamine-secreting pheochromocytoma. Am J Med 57: 953-956, 1974.","DOI":"10.1016\/0002-9343(74)90174-0"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Levitt RG, Stanley RJ, Dehner LP. Angiography of a clinically nonfunctioning pheochromocytoma. Case report and review of the literature. JAMA 233: 268-269, 1975.","DOI":"10.1001\/jama.1975.03260030058025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Krane NK. Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review of the literature. Arch Intern Med 146: 54-57, 1986.","DOI":"10.1001\/archinte.1986.00360130064008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kopetschke R, Slisko M, Kilisli A, et al. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol 161: 355-361, 2009.","DOI":"10.1530\/EJE-09-0384"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5857-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:55Z","timestamp":1777692115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5857-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5857-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"5857-25"}}